A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin

Christina Trambas, Federico Gallo, Daniela Pende, Stefania Marcenaro, Lorenzo Moretta, Carmela De Fusco, Alessandra Santoro, Luigi Notarangelo, Maurizio Arico, Gillian M. Griffiths

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Mutations in the perform gene have been found in patients with hemophagocytic lymphohistiocytosis (HLH), a rare autosomal recessive disease. We describe a patient expressing perform with amino acid changes A91V and W374X. The ability of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to lyse target cells is greatly reduced. Here we demonstrate that perform from this patient is not recognized using an antibody raised against native perform (δG9), but is readily detected using an antibody raised against a peptide epitope (2d4), suggesting that the epitope recognized by δG9 is destroyed by the change at A91V. Immunoblotting reveals no protein corresponding to the truncated transcript encoded by W374X, revealing that only perform with the A91V change Is expressed in CTLs from the patient. Patient CTLs show bands corresponding to the immature and intermediate forms of perform, but the mature active form of perform is absent or barely detectable. The conformational changes and impaired cleavage of A91V perform are likely to explain the reduced cytotoxicity in CTLs and NK cells from this patient and are likely to contribute to the pathogenesis of HLH.

Original languageEnglish
Pages (from-to)932-937
Number of pages6
JournalBlood
Volume106
Issue number3
DOIs
Publication statusPublished - Aug 1 2005

Fingerprint

Perforin
T-cells
Cytotoxic T-Lymphocytes
Amino Acids
Processing
Hemophagocytic Lymphohistiocytosis
Epitopes
Natural Killer Cells
Antibodies
Cytotoxicity
Genes
Immunoblotting
Peptides
Mutation
Proteins

ASJC Scopus subject areas

  • Hematology

Cite this

A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. / Trambas, Christina; Gallo, Federico; Pende, Daniela; Marcenaro, Stefania; Moretta, Lorenzo; De Fusco, Carmela; Santoro, Alessandra; Notarangelo, Luigi; Arico, Maurizio; Griffiths, Gillian M.

In: Blood, Vol. 106, No. 3, 01.08.2005, p. 932-937.

Research output: Contribution to journalArticle

Trambas, C, Gallo, F, Pende, D, Marcenaro, S, Moretta, L, De Fusco, C, Santoro, A, Notarangelo, L, Arico, M & Griffiths, GM 2005, 'A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin', Blood, vol. 106, no. 3, pp. 932-937. https://doi.org/10.1182/blood-2004-09-3713
Trambas, Christina ; Gallo, Federico ; Pende, Daniela ; Marcenaro, Stefania ; Moretta, Lorenzo ; De Fusco, Carmela ; Santoro, Alessandra ; Notarangelo, Luigi ; Arico, Maurizio ; Griffiths, Gillian M. / A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. In: Blood. 2005 ; Vol. 106, No. 3. pp. 932-937.
@article{da9513e085a644689e15f504fb55b7be,
title = "A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin",
abstract = "Mutations in the perform gene have been found in patients with hemophagocytic lymphohistiocytosis (HLH), a rare autosomal recessive disease. We describe a patient expressing perform with amino acid changes A91V and W374X. The ability of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to lyse target cells is greatly reduced. Here we demonstrate that perform from this patient is not recognized using an antibody raised against native perform (δG9), but is readily detected using an antibody raised against a peptide epitope (2d4), suggesting that the epitope recognized by δG9 is destroyed by the change at A91V. Immunoblotting reveals no protein corresponding to the truncated transcript encoded by W374X, revealing that only perform with the A91V change Is expressed in CTLs from the patient. Patient CTLs show bands corresponding to the immature and intermediate forms of perform, but the mature active form of perform is absent or barely detectable. The conformational changes and impaired cleavage of A91V perform are likely to explain the reduced cytotoxicity in CTLs and NK cells from this patient and are likely to contribute to the pathogenesis of HLH.",
author = "Christina Trambas and Federico Gallo and Daniela Pende and Stefania Marcenaro and Lorenzo Moretta and {De Fusco}, Carmela and Alessandra Santoro and Luigi Notarangelo and Maurizio Arico and Griffiths, {Gillian M.}",
year = "2005",
month = "8",
day = "1",
doi = "10.1182/blood-2004-09-3713",
language = "English",
volume = "106",
pages = "932--937",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "3",

}

TY - JOUR

T1 - A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin

AU - Trambas, Christina

AU - Gallo, Federico

AU - Pende, Daniela

AU - Marcenaro, Stefania

AU - Moretta, Lorenzo

AU - De Fusco, Carmela

AU - Santoro, Alessandra

AU - Notarangelo, Luigi

AU - Arico, Maurizio

AU - Griffiths, Gillian M.

PY - 2005/8/1

Y1 - 2005/8/1

N2 - Mutations in the perform gene have been found in patients with hemophagocytic lymphohistiocytosis (HLH), a rare autosomal recessive disease. We describe a patient expressing perform with amino acid changes A91V and W374X. The ability of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to lyse target cells is greatly reduced. Here we demonstrate that perform from this patient is not recognized using an antibody raised against native perform (δG9), but is readily detected using an antibody raised against a peptide epitope (2d4), suggesting that the epitope recognized by δG9 is destroyed by the change at A91V. Immunoblotting reveals no protein corresponding to the truncated transcript encoded by W374X, revealing that only perform with the A91V change Is expressed in CTLs from the patient. Patient CTLs show bands corresponding to the immature and intermediate forms of perform, but the mature active form of perform is absent or barely detectable. The conformational changes and impaired cleavage of A91V perform are likely to explain the reduced cytotoxicity in CTLs and NK cells from this patient and are likely to contribute to the pathogenesis of HLH.

AB - Mutations in the perform gene have been found in patients with hemophagocytic lymphohistiocytosis (HLH), a rare autosomal recessive disease. We describe a patient expressing perform with amino acid changes A91V and W374X. The ability of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to lyse target cells is greatly reduced. Here we demonstrate that perform from this patient is not recognized using an antibody raised against native perform (δG9), but is readily detected using an antibody raised against a peptide epitope (2d4), suggesting that the epitope recognized by δG9 is destroyed by the change at A91V. Immunoblotting reveals no protein corresponding to the truncated transcript encoded by W374X, revealing that only perform with the A91V change Is expressed in CTLs from the patient. Patient CTLs show bands corresponding to the immature and intermediate forms of perform, but the mature active form of perform is absent or barely detectable. The conformational changes and impaired cleavage of A91V perform are likely to explain the reduced cytotoxicity in CTLs and NK cells from this patient and are likely to contribute to the pathogenesis of HLH.

UR - http://www.scopus.com/inward/record.url?scp=20344406945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344406945&partnerID=8YFLogxK

U2 - 10.1182/blood-2004-09-3713

DO - 10.1182/blood-2004-09-3713

M3 - Article

C2 - 15741215

AN - SCOPUS:20344406945

VL - 106

SP - 932

EP - 937

JO - Blood

JF - Blood

SN - 0006-4971

IS - 3

ER -